Abstract
Tay-Sachs disease is an autosomal recessive lysosomal storage disease caused by β-hexosaminidase A deficiency and leads to death in early childhood. The disease results from mutations in the HEXA gene, which codes for the α chain of β-hexosaminidase. The catastrophic neurodegenerative progression of the disease is thought to be a consequence of massive neuronal accumulation of GM2 ganglioside and related glycolipids in the brain and nervous system of the patients. Fuller understanding of the pathogenesis and the development of therapeutic procedures have both suffered from the lack of an animal model. We have used gene targeting in embryonic stem (ES) cells to disrupt the mouse Hexa gene. Mice homozygous for the disrupted allele mimic several biochemical and histological features of human Tay-Sachs disease. Hexa-/-mice displayed a total deficiency of β-hexosaminidase A activity, and membranous cytoplasmic inclusions typical of GM2 gangliosidoses were found in the cytoplasm of their neurons. However, while the number of storage neurons increased with age, it remained low compared with that found in human, and no apparent motor or behavioral disorders could be observed. This suggests that the presence of β-hexosaminidase A is not an absolute requirement of ganglioside degradation in mice. These mice should help us to understand several aspects of the disease as well as the physiological functions of hexosaminidase in mice. They should also provide a valuable animal model in which to test new forms of therapy, and in particular gene delivery into the central nervous system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adachi, M., Volk, B.W., Schneck, L., Relkin, R. (1974). Ultrastructural studies of eight cases of fetal Tay-Sachs disease. Lab. Invest. 30, 102.
Akli, S., Chelly, J., Lacorte, J.M., Poenaru, L., Kahn, A. (1991). Seven novel Tay-Sachs mutations detected by chemical mismatch cleavage of PCR-amplified cDNA fragments. Genomics 11, 124–134.
Akli, S., Boué, J., Kleijer, W., Vamos, E., Young, E., Gatti, R., DiNatale, P., Motte, A., Vanier, M.T., Maire, I., Miranda, C., Salvaire, R., Sandhoff, K., Poenaru, L. (1993). Collaborative study of molecular epidemiology of Tay-Sachs disease in Europe. Eur. J. Hum. Genet. 1, 229–238.
Andermann, E., Andermann, F., Patry, G., Lafontaine, R., Geoffroy, G., Seriver, C.R., Wolfe, L.S. (1971). Tay-Sachs disease in Quebec: evidence for a geographic aggregate in the French-Canadian population with identification of a new retardation syndrome with possible linkage to the Tay-Sachs gene. Trans. Am. Neurol. Assoc. 98, 17–21.
Bapat, B., Ethier, M., Neote, K., Mahuran, D., Gravel, R.A. (1988). Cloning and sequence of a cDNA encoding the β-subunit of mouse β-hexosaminidase. FEBS Lett. 237, 191–195.
Bayrelan, J., Hechtman, P., Saray, W. (1984). Synthesis of 4-methylumbelliferyl β-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes. Clin. Chim. Acta. 143, 73–89.
Beccari, T., Orlacchio, A., Stirling, J.L. (1988). Identification of β-N-acetylhexosaminidase A in mouse tissues with the fluorogenic substrate 4-methylumbelliferyl-β-N-acetylglucosamine 6-sulphate. Biochem. J. 252, 617–620.
Beccari, T., Hoade, J., Orlacchio, A., Stirling, J.L. (1992). Cloning and sequence analysis of a cDNA encoding the α-subunit of mouse β-N-acetylhexosaminidase and comparison with the human enzyme. Biochem. J. 285, 593–596.
Boedecker, H.J., Mellman, W.J., Tedesco, T.A., Croce, C.M. (1976). Assignment of the human gene for HEXB to chromosome 5. Exp. Cell. Res. 93, 468–472.
Burg, J., Banerjee, A., Conzelmann, E., Sandhoff, K. (1983). Activating proteins for gangliosides GM2 degradation by β-hexosaminidase isoenzymes in tissue extracts from different species. Hoppe-Seyler's Z. Physiol. Chem. 364, 821–829.
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J., Rutter, W.J. (1979). Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299.
Cork, L.C., Munnell, J.F., Lorentz, M.D., Murphy, J.V., Baker, J.H., Rattazzi, M.C. (1977). GM2 ganglioside lysosomal storage disease in cats with β-hexosaminidase deficiency. Science 196, 1014–1017.
Della Fazia, M.A., Beccari, T., Servillo, G., Viola-Magni, M.P., Orlacchio, A. (1994). Different expression of β-N-acetylhexosaminidase in mouse tissues. Biochem. Biophys. Res. Commun. 199, 1341–1346.
Enquist, L.W., Vande-Woude, G.F., Wagner, M., Smiley, J.R., Summers, W.C. (1979). Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus. Gene 7, 335–342.
Farooqui, A., Srivastava, P.N. (1980). Isolation of β-N-acetylhexosaminidase from rabbit semen and its role in fertilization. Biochem. J. 191, 827–834.
Gilbert, F., Kucherlopati, R., Creagan, R.P., Murnane, M.J., Darlington, G.J., Ruddle, F.H. (1975). Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosome. Proc. Natl. Acad. Sci. USA 72, 263–267.
Ishikawa, Y., Li, S.-C., Wood, P.A., Li, Y.-T. (1987). Biochemical basis of type AB GM2 gangliosidosis in a Japanese spaniel. J. Neurochem. 48, 860–864.
Korneluk, R.G., Mahuran, D.J., Neote, K., Klavins, M.H., O'Dowd, B.F., Tropak, M., Willard, H.F., Anderson, M.-J., Lowden, J.A., Gravel, R.A. (1986). Isolation of cDNA clones for the α-subunit of human β-hexosaminidase. J. Biol. Chem. 261, 8407–8413.
Kosanke, S.D., Pierce, K.R., Bay, W.W. (1978). Clinical and biochemical abnormalities in porcine GM2-gangliosidosis. Vet. Pathol. 15, 685–699.
Leinekugel, P., Michel, S., Conzelman, E., Sandhoff, K. (1992). Quantitative correlation between the residual activity of β-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum. Genet. 88, 513–523.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, P.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275.
Maertens, P., Dyken, P.R. (1995). Neurological degenerative diseases. In Pediatric Neuropathology, Serge Duckett, ed. (Baltimore: Williams & Wilkins), pp. 545–591.
Mahuran, D.J. (1991). The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis. Biochem. Biophys. Acta 1991, 87–94.
Mansour, S.L., Thomas, K.R., Capecchi, M.R. (1988). Disruption of the protooncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348–352.
Miller, D.J., Gong, X., Shur, B.D. (1993). Sperm require β-N-acetylglucosaminidase to penetrate through the egg zona pellucida. Development 118, 1279–1289.
Myerowitz, R., Piekarz, R., Neufeld, E.F., Shows, T.B., Suzuki, K. (1985). Human β-hexosaminidase α chain: coding sequence and homology with the β chain. Proc. Natl. Acad. Sci. USA 82, 7830–7834.
Neote, K., Bapat, B., Dumbrille-Ross, A., Troxal, C., Schuster, S.M., Mahuran, D.J., Gravel, R.A. (1988). Characterization of the human HEXB gene encoding lysosomal β-hexosaminidase. Genomics 3, 279–286.
Neufeld, E.F. (1989). Natural history and inherited disorders of a lysosomal enzyme, β-hexosaminidase. J. Biol. Chem. 264, 10927–10930.
Neuwelt, E.A., Jonshon, W.G., Blank, N.K., Pagel, M.A., Malsen-McClure, C., McClure, M.J., Wu, P.M. (1985). Characterization of a new model of GM2-gangliosidosis (Sandhoff's disease) in Koratz cats. J. Clin. Invest. 76, 482–490.
Petersen, G., Rotter, J., Cantor, R., Field, L., Greenwald, S., Lim, J., Roy, C., Schoenfeld, J., Lowden, A., Kaback, M. (1983). The geographic variation and origin of the Tay-Sachs disease gene in North American Jewish and non-Jewish populations. Am. J. Hum. Genet. 35, 1258–1269.
Proia, R.L. (1988). Gene encoding the human β-hexosaminidase β chain: extensive homology of intron placement in the α-and β-chain genes. Proc. Natl. Acad. Sci. USA 85, 1883–1887.
Robertson, E.J., Bradley, A. (1986). Production of permanent cell lines from early embryos and their use in studying developmental problems. In Experimental Approaches to Mammalian Embryonic Development, J.R. Pedersen and R.A. Pedersen, eds. (Oxford: IRL Press), pp. 475–508.
Sandhoff, K., Conzelman, E., Neufeld, E.F., Kabach, M.M., Suzuki, K. (1989). The GM2 gangliosidoses. In: The Metabolic Basis of Inherited Diseases, C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, eds. (New York: McGraw-Hill), pp. 1807–1839.
Stirling, J.L., Beccari, T., Hoade, J., Pezzetti, F., Calvitti, M., Bechetti, E., Orlacchio, A. (1991). Analysis of the patterns of expression of mRNAs for the alpha-and beta-subunits of the lysosomal enzyme beta-N-acetylhexosaaminidase in mouse epididymis and testis. Histochem. J. 23, 490–494.
von Specht, B., Geiger, B., Arnon, R., Passwell, J., Keren, G., Goldman, B., Padeh, B. (1979). Enzyme replacement in Tay-Sachs disease. Neurology 29, 848–854.
Wakamatsu, N., Benoit, G., Lamhonwah, A.-M., Zhang, Z.-X., Trasler, J.M., Triggs-Raine, B.L., Gravel, R.A. (1994). Structural organization, sequence and expression of the mouse HEXA gene encoding the α subunit of hexosaminidase A. Genomics 24, 110–119.
Wu, C.-L., Melton, D.W. (1993). Production of a model for Leish-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nature Genet. 3, 235–240.
Yamanaka, S., Jonshon, M.D., Grinberg, A., Westphal, H., Crawley, J.N., Tanike, M., Suzuki, K., Proia, R.L. (1994). Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc. Natl. Acad. Sci. USA 91, 9975–9979.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen-Tannoudji, M., Marchand, P., Akli, S. et al. Disruption of murine Hexa gene leads to enzymatic deficiency and to neuronal lysosomal storage, similar to that observed in Tay-Sachs disease. Mammalian Genome 6, 844–849 (1995). https://doi.org/10.1007/BF00292433
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00292433